Literature DB >> 20723636

Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Michael C Tjandrawidjaja1, Yuling Fu, Cynthia M Westerhout, Galen S Wagner, Christopher B Granger, Paul W Armstrong.   

Abstract

The prognostic value of myocardial infarct size estimation by QRS scoring in patients with ST-segment elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (PCI) is unclear. The standard 32-point Selvester QRS score on the discharge electrocardiogram (each point approximately 3% left ventricular mass) was calculated in 4,113 patients with STEMI who underwent primary PCI and survived to hospital discharge in the APEX-AMI trial. QRS scores were divided into tertiles, i.e., < or =3 (<10% myocardium), 4 to 7 (10% to 21% myocardium), and > or =8 (>21% myocardium). Adjusted associations between QRS score and 90-day outcomes (death and composite of death/congestive heart failure (CHF)/shock) were examined. Higher QRS scores were associated with male gender, higher heart rate, worse Killip class, noninferior infarct location, greater ST-segment deviation, and longer times to reperfusion. Higher QRS scores were also associated with impaired culprit artery flow before and after PCI and more frequent multivessel disease. Adverse outcomes occurred more often in patients with higher QRS scores (90-day death: 1.9%, QRS score 0 to 3; 3.4%, 4 to 7; 4.9%, > or =8; 90-day death/shock/CHF: 4.5%, 0-3; 7.8%, 4 to 7; 12.1%, > or =8). After multivariable adjustment, patients with higher QRS scores remained more likely to develop an adverse outcome versus those with QRS scores < or =3 (score 4 to 7, hazard ratios [HR] for death 2.08, 95% confidence interval [CI] 1.26 to 3.41; HR for death/CHF/shock 2.00, 95% CI 1.26 to 3.17; score > or =8, HR for death 2.57, 95% CI 1.56 to 4.24, HR for death/CHF/shock 2.93, 95% CI 1.84 to 4.67). In conclusion, infarct size as estimated by QRS scoring at hospital discharge is an independent and prognostically relevant metric in patients with STEMI undergoing primary PCI. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723636     DOI: 10.1016/j.amjcard.2010.04.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  The year of 2010 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

2.  Screening entire health system ECG databases to identify patients at increased risk of death.

Authors:  David G Strauss; Nathan Mewton; Richard L Verrier; Bruce D Nearing; Francis E Marchlinski; Tony Killian; John Moxley; Larisa G Tereshchenko; Katherine C Wu; Raimond Winslow; Christopher Cox; Peter M Spooner; João A C Lima
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-10-12

3.  Differences in the Selvester QRS score after primary PCI strategy and conservative treatment for STEMI patients with negative T waves.

Authors:  Egle Kalinauskiene; Dalia Gerviene; Ljuba Bacharova; Zora Krivosikova; Albinas Naudziunas
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-08-01       Impact factor: 1.468

4.  A detailed guide for quantification of myocardial scar with the Selvester QRS score in the presence of electrocardiogram confounders.

Authors:  Zak Loring; Sreetharan Chelliah; Ronald H Selvester; Galen Wagner; David G Strauss
Journal:  J Electrocardiol       Date:  2011 Sep-Oct       Impact factor: 1.438

5.  Relationship between Selvester ECG Score and Cardiovascular Outcomes in Patients with Non-ST Elevation Myocardial Infarction.

Authors:  Osman Can Yontar; Guney Erdogan; Mustafa Yenercag; Sefa Gul; Ugur Arslan; Ali Karagoz
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

6.  Screening for Cardiac Magnetic Resonance Scar Features by 12-Lead ECG, in Patients with Preserved Ejection Fraction.

Authors:  Nathan Mewton; David G Strauss; Patricia Rizzi; Richard L Verrier; Chia Ying Liu; Larisa G Tereshchenko; Bruce Nearing; Gustavo J Volpe; Francis E Marchlinski; John Moxley; Tony Killian; Katherine C Wu; Peter Spooner; João A C Lima
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-01       Impact factor: 1.468

7.  In Comparison to Pathological Q Waves, Selvester Score is a Superior Diagnostic Indicator of Increased Long-Term Mortality Risk in ST Elevation Myocardial Infarction Patients Treated with Primary Coronary Intervention.

Authors:  Maria Holicka; Pavla Cuckova; Katerina Hnatkova; Lumir Koc; Tomas Ondrus; Petr Lokaj; Jiri Parenica; Tomas Novotny; Petr Kala; Marek Malik
Journal:  Diagnostics (Basel)       Date:  2021-04-28

8.  QRS duration predicts 30 day mortality following ST elevation myocardial infarction.

Authors:  Chinualumogu Nwakile; Bhaskar Purushottam; Jeong Yun; Vikas Bhalla; D Lynn Morris; Vincent M Figueredo
Journal:  Int J Cardiol Heart Vasc       Date:  2014-11-07

9.  PPARα activation alleviates damage to the cytoskeleton during acute myocardial ischemia/reperfusion in rats.

Authors:  Jie Yuan; Hongdan Mo; Jing Luo; Suhong Zhao; Shuang Liang; Yu Jiang; Maomao Zhang
Journal:  Mol Med Rep       Date:  2018-03-16       Impact factor: 2.952

10.  Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?

Authors:  Jay Shavadia; Yinggan Zheng; Neda Dianati Maleki; Kurt Huber; Sigrun Halvorsen; Patrick Goldstein; Anthony H Gershlick; Robert Wilcox; Frans Van de Werf; Paul W Armstrong
Journal:  J Am Heart Assoc       Date:  2015-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.